首页 › 基金 › GordonMD Global Investments LP › KYTX
GordonMD Global Investments LP 对 KYTX 的持仓历史
KYVERNA THERAPEUTICS INC · 医疗保健
GordonMD Global Investments LP 在 Q3 2026 的 13F 申报中披露持有 KYTX(KYVERNA THERAPEUTICS INC)4,521,318 股,市值约 US$30.7M,约占其申报组合的 18.47%,在其申报持仓中市值排名第 2 位。 GordonMD Global Investments LP 最近 4 个申报季度中有 4 个季度披露了 KYTX 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
GordonMD Global Investments LP 对 KYTX 的持仓演变
GordonMD Global Investments LP 于 Q4 2025 首次披露 KYTX 持仓:4,391,818 股(约 US$41.3M)。 在 4 次申报中,GordonMD Global Investments LP 1 次增持、1 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 4,521,318 股、市值约 US$30.7M,环比增持 276,500 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 4.39M | $41.28M | 新进 |
| Q1 2026 | 4.24M | $36.63M | 减持 |
| Q2 2026 | 4.24M | $37.82M | 持有 |
| Q3 2026 | 4.52M | $30.74M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 KYTX 与 13F 数据
KYTX(KYVERNA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 39 只申报持有 KYTX,申报仓位最大的包括:GILEAD SCIENCES, INC. (US$28.1M), AIGH Capital Management LLC (US$24.8M), Bain Capital Life Sciences Investors, LLC (US$8.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 KYTX 的基金
- GILEAD SCIENCES, INC. 4.13M 股 · $28.06M · Q3 2026
- AIGH Capital Management LLC 3.65M 股 · $24.82M · Q3 2026
- Bain Capital Life Sciences Investors, LLC 1.31M 股 · $8.92M · Q3 2026
- Insight Holdings Group, LLC 989.05K 股 · $8.81M · Q2 2026
- MBB PUBLIC MARKETS I LLC 614.48K 股 · $5.47M · Q2 2026
- Propel Bio Management, LLC 700.60K 股 · $4.76M · Q3 2026
更多关于 GordonMD Global Investments LP
常见问题
How long has GordonMD Global Investments LP held KYTX?
GordonMD Global Investments LP has disclosed KYTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is GordonMD Global Investments LP's current position in KYTX?
As of Q3 2026, GordonMD Global Investments LP holds 4.52M shares of KYTX (KYVERNA THERAPEUTICS INC), valued at $30.74M, representing 18.47% of its reported portfolio and ranking #2.
Has GordonMD Global Investments LP been buying or selling KYTX?
In the latest 13F filing (Q3 2026), GordonMD Global Investments LP increased its position in KYTX.
Which other funds hold KYTX?
Other major institutional holders of KYTX include GILEAD SCIENCES, INC., AIGH Capital Management LLC, Bain Capital Life Sciences Investors, LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.